Ottobock Reinforces Its Innovation Leadership on World Intellectual Property Day

Ottobock SE & Co. KGaA, a leader in prosthetics, neuro-orthotics, and exoskeletons, boasts an impressive portfolio of 2,110 patents, 22 first filings, and 639 patent families. This portfolio underscores the company's dedication to innovation and technology leadership in medtech. The focus of Ottobock's property rights highlights its core segments in these fields.

Chief Technology Officer Arne Jörn emphasizes the strategic importance of patents as a representation of Ottobock's pursuit to advance medtech standards. The company integrates biomechanics, robotics, and AI, resulting in a broad and interconnected patent portfolio.

A notable patent, US 12,494,278 B2, enhances control of microprocessor-controlled prostheses, improving user precision and safety. Ottobock's IP strategy provides legal security and sustains its technological leadership, crucial for long-term innovation planning.